Christine Blank, Contributing Editor
Nevada Law on Diabetes Meds Has a Setback
The Nevada law to fight high diabetes drug prices has stumbled.
New Programs Aim to Curb Diabetes Drug Costs
Drug makers are starting plans to help patients pay for diabetes drugs.
Keep prescription drug benefits in ACA, NCPA urges
NCPA sends letter to Senate on prescription issues in health-care reform.
Costly new ALS treatment approved
FDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.
Campaign gears up to combat high drug prices
Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.
FDA approves first targeted leukemia drug for certain patients, plus 2 more
Late last week, FDA approved a new drug to treat acute myeloid leukemia (AML), the first treatment for Batten disease, and expanded the use of a current drug to treat liver cancer.
New abuse-deterrent opioid available
A new abuse-deterrent painkiller - oxycodone hydrochloride (RoxyBond, Inspirion Delivery Services) - will be available soon after receiving FDA approval.
FDA clears second Remicade biosimilar
In what is expected to produce hefty saving for rheumatoid arthritis patients and the healthcare system, FDA approved the second biosimilar to Remicade (Johnson & Johnson).
FDA: Limit codeine and tramadol use in kids
FDA said this week that it is restricting the use of codeine and tramadol medicines in children. The drug’s labels will now include a contraindication that codeine should not be used to treat pain or cough, and that tramadol should not be used to treat pain, in children younger than 12 years.
CVS: Generics and Biosimilars Are Key to Its Drug Spending Decline
Drug spending is going down at CVS Caremark. Here’s why.


View Results